TNON
Tenon Medical, Inc.NASDAQHealthcare$0.72+3.95%ClosedMarket Cap: $5.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.60
P/S
1.39
EV/EBITDA
-0.15
DCF Value
$-63.07
FCF Yield
-200.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
59.1%
Operating Margin
-323.6%
Net Margin
-316.0%
ROE
-193.2%
ROA
-116.4%
ROIC
-166.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.5M | 66.7% | $-2.9M | $-2.8M | $-0.26 | — |
| FY 2025 | $3.9M | 59.8% | $-12.8M | $-12.6M | $-1.70 | — |
| Q3 2025 | $1.2M | 65.9% | $-3.4M | $-3.3M | $-0.40 | — |
| Q2 2025 | $564.0K | 43.4% | $-2.9M | $-2.8M | $-0.36 | — |
| Q1 2025 | $726.0K | 44.5% | $-3.7M | $-3.6M | $-1.01 | — |
| Q4 2024 | $770.0K | 45.8% | $-3.2M | $-3.1M | $-2.54 | — |
| FY 2024 | $3.3M | 52.2% | $-13.8M | $-13.7M | $-11.26 | — |
| Q3 2024 | $887.0K | 47.1% | $-3.2M | $-3.2M | $-3.63 | — |
| Q2 2024 | $901.0K | 52.2% | $-3.9M | $-3.8M | $-8.16 | — |
| Q1 2024 | $719.0K | 65.4% | $-3.5M | $-3.6M | $-10.03 | — |
| Q4 2023 | $808.0K | 50.5% | $-3.1M | $-3.1M | $-9.85 | — |
| FY 2023 | $2.9M | 42.4% | $-15.7M | $-15.6M | $-68.64 | — |